Check out our latest news
An update about COVID-19
MSWA remains alert as we monitor the COVID-19 situation. This article provides a current updates and useful links for further information.
Vumerity medication for relapsing-remitting MS, now approved under PBS
Vumerity® (diroximel fumarate) will be listed under the Pharmaceutical Benefit Scheme (PBS).
We thank Ros Harman
Ros Harman has announced her resignation from the MSWA Board after 18 years of service and valued contribution.